Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Ecolab
ECL
$78.1B
| $13.6M | 0.03% |
+119,222
| New | +$14M |
|
777
Zoetis
ZTS
$30.4B
| $13.6M | 0.03% |
283,400
-602,800
| -68% | -$27.2M |
|
778
First Industrial Realty Trust
FR
$8.4B
| $13.6M | 0.03% |
613,300
-102,400
| -14% | -$2.26M |
|
|
ARRY
779
DELISTED
Array Biopharma Inc
ARRY
| $13.5M | 0.03% |
3,210,394
+2,280,966
| +245% | +$10.4M |
|
|
NRF
780
DELISTED
NorthStar Realty Finance Corp.
NRF
| $13.5M | 0.03% |
794,396
+446,050
| +128% | +$8.98M |
|
|
CSCD
781
DELISTED
CASCADE MICROTECH, INC.
CSCD
| $13.5M | 0.03% |
830,600
+75,900
| +10% | +$1.2M |
|
|
TFCFA
782
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $13.5M | 0.03% |
496,400
-1,017,400
| -67% | -$29.5M |
|
|
RSE
783
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $13.5M | 0.03% |
925,000
+359,600
| +64% | +$5.87M |
|
784
Cal-Maine
CALM
$3.86B
| $13.5M | 0.03% |
290,400
-282,516
| -49% | -$15.2M |
|
|
GNC
785
DELISTED
GNC Holdings, Inc.
GNC
| $13.4M | 0.03% |
433,580
-474,310
| -52% | -$16M |
|
786
Enbridge
ENB
$112B
| $13.4M | 0.03% |
403,569
+400
| +0.1% | +$15K |
|
787
Booz Allen Hamilton
BAH
$9.43B
| $13.4M | 0.03% |
433,894
-764,906
| -64% | -$22.2M |
|
|
GOOD
788
Gladstone Commercial Corp
GOOD
$630M
| $13.4M | 0.03% |
915,500
-65,100
| -7% | -$976K |
|
789
Dolby
DLB
$5.75B
| $13.4M | 0.03% |
396,900
+23,300
| +6% | +$800K |
|
790
Emerson Electric
EMR
$91.4B
| $13.3M | 0.03% |
278,600
+130,200
| +88% | +$6.2M |
|
791
Comscore
SCOR
$108M
| $13.3M | 0.03% |
16,180
-2,120
| -12% | -$1.84M |
|
792
Southwest Airlines
LUV
$22B
| $13.3M | 0.03% |
309,180
+155,380
| +101% | +$6.88M |
|
793
Ryder
R
$10.1B
| $13.3M | 0.03% |
+234,200
| New | +$15.5M |
|
794
KBR
KBR
$4.8B
| $13.3M | 0.03% |
783,400
+336,700
| +75% | +$6.18M |
|
|
PFSW
795
DELISTED
PFSweb, Inc.
PFSW
| $13.3M | 0.03% |
1,029,839
-95,700
| -9% | -$1.32M |
|
|
AMSG
796
DELISTED
Amsurg Corp
AMSG
| $13.2M | 0.03% |
174,269
+170,500
| +4,524% | +$13.5M |
|
|
LLL
797
DELISTED
L3 Technologies, Inc.
LLL
| $13.2M | 0.03% |
+110,800
| New | +$13.2M |
|
798
Atlantic Union Bankshares
AUB
$6.06B
| $13.2M | 0.03% |
523,005
+74,100
| +17% | +$1.91M |
|
|
TSYS
799
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $13.2M | 0.03% |
2,648,069
+710,669
| +37% | +$3.15M |
|
|
NUTR
800
DELISTED
Nutraceutical International Co
NUTR
| $13.2M | 0.03% |
509,700
+118,400
| +30% | +$2.91M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.